Pembrolizumab Market Growth Gains Momentum Amid Rising Cancer Incidence Worldwide
The Pembrolizumab Market size was valued at US$ 26.47 billion in 2025 and is projected to reach US$ 57.46 billion by 2033, growing at a CAGR of 10.1% from 2026 to 2033, driven by increasing cancer incidence, expanding immunotherapy adoption, clinical advancements, biomarker-guided therapies, and oncology treatment innovation.
https://www.businessmarketinsi....ghts.com/reports/pem
Мне нравится
Комментарий
Поделиться
